Dual neonate vaccine platform against HIV-1 and M. tuberculosis.

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.

Acquired immunodeficiency syndrome and tuberculosis (TB) are two of the world's most devastating diseases. The first vaccine the majority of infants born in Africa receive is Mycobacterium bovis bacillus Calmette-Guerin (BCG) as a prevention against TB. BCG protects against disseminated disease...

Detaylı Bibliyografya
Asıl Yazarlar:	Hopkins, R, Bridgeman, A, Joseph, J, Gilbert, S, McShane, H, Hanke, T
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Public Library of Science 2011

Benzer Materyaller

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
Yazar:: Richard Hopkins, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Vaccine strategies against tuberculosis
Yazar:: H McShane
Baskı/Yayın Bilgisi: (2009-03-01)

Vaccines for tuberculosis
Yazar:: McShane, H
Baskı/Yayın Bilgisi: (2013)

Vaccine Platform for Prevention of Mother-to-Child Transmission of HIV-1 through Breastfeeding
Yazar:: Im, E, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Insights and challenges in tuberculosis vaccine development
Yazar:: McShane, H
Baskı/Yayın Bilgisi: (2019)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
Yazar:: McShane, H
Baskı/Yayın Bilgisi: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
Yazar:: McShane, H
Baskı/Yayın Bilgisi: (2011)

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis
Yazar:: Christopher J. De Voss, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

Vaccination against tuberculosis: how can we better BCG?
Yazar:: Pitt, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Vaccination against tuberculosis: How can we better BCG?
Yazar:: Pitt, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Tuberculosis vaccines: Progress and challenges
Yazar:: Checkley, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Vaccine strategies against tuberculosis.
Yazar:: Mcshane, H
Baskı/Yayın Bilgisi: (2009)

Developing an improved vaccine against tuberculosis.
Yazar:: Mcshane, H
Baskı/Yayın Bilgisi: (2004)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
Yazar:: McShane, H
Baskı/Yayın Bilgisi: (2023)

Why don’t we have an effective tuberculosis vaccine yet?
Yazar:: Davenne, T, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Clinical testing of tuberculosis vaccine candidates
Yazar:: Hatherill, M, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy
Yazar:: Vermaak, S, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research
Yazar:: Tanner, R, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

WHO preferred product characteristics for new vaccines against tuberculosis
Yazar:: Schrager, L, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding.
Yazar:: Im, E, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
Yazar:: Dockrell, HM, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
Yazar:: Griffiths, K, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Construction and characterization of recombinant MTBVAC. HIV, a new live attenuated vaccine against HIV and tuberculosis
Yazar:: Saubi, N, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
Yazar:: Hazel M. Dockrell, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
Yazar:: Villarreal-Ramos, B, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.
Yazar:: Sander, C, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Human and Bovine Tuberculosis
Yazar:: McShane, H
Baskı/Yayın Bilgisi: (2016)

MTBVAC-based TB-HIV vaccine is safe, elicits HIV-T cell responses, and protects against Mycobacterium tuberculosis in Mice
Yazar:: Broset, E, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine.
Yazar:: Bridgeman, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
Yazar:: Esther Broset, ve diğerleri
Baskı/Yayın Bilgisi: (2019-06-01)

Identification of antigens presented by MHC for vaccines against tuberculosis
Yazar:: Bettencourt, P, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Identification of antigens presented by MHC for vaccines against tuberculosis
Yazar:: Bettencourt, P, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
Yazar:: Stylianou, E, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
Yazar:: Dean, G, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

MVA as a vector for vaccines against HIV-1.
Yazar:: Im, E, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Engineering a dual vaccine against COVID-19 and tuberculosis
Yazar:: Carlyn Monèt Guthrie, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Controlled human infection models: is it really feasible to give people tuberculosis?
Yazar:: McShane, H
Baskı/Yayın Bilgisi: (2020)

Local pulmonary immunological biomarkers in tuberculosis
Yazar:: Morrison, H, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Local Pulmonary Immunological Biomarkers in Tuberculosis
Yazar:: Hazel Morrison, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Tuberculosis vaccines in clinical trials.
Yazar:: Rowland, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)